BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36475318)

  • 21. Prediction of cancer incidence and mortality in Korea, 2014.
    Jung KW; Won YJ; Kong HJ; Oh CM; Lee DH; Lee JS
    Cancer Res Treat; 2014 Apr; 46(2):124-30. PubMed ID: 24851103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Trends in the Incidence Rates of Central Retinal Artery Occlusion in Korea From 2002 to 2015.
    Kim J; Byun SJ; Woo SJ; Park KH; Park SJ
    JAMA Ophthalmol; 2021 Apr; 139(4):399-405. PubMed ID: 33570556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.
    De P; Otterstatter MC; Semenciw R; Ellison LF; Marrett LD; Dryer D
    Cancer Causes Control; 2014 Oct; 25(10):1271-81. PubMed ID: 25034462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer incidence and mortality projections in the UK until 2035.
    Smittenaar CR; Petersen KA; Stewart K; Moitt N
    Br J Cancer; 2016 Oct; 115(9):1147-1155. PubMed ID: 27727232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Mortality Projections in Korea up to 2032.
    Son M; Yun JW
    J Korean Med Sci; 2016 Jun; 31(6):892-901. PubMed ID: 27247498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annual report to the nation on the status of cancer, part I: National cancer statistics.
    Henley SJ; Ward EM; Scott S; Ma J; Anderson RN; Firth AU; Thomas CC; Islami F; Weir HK; Lewis DR; Sherman RL; Wu M; Benard VB; Richardson LC; Jemal A; Cronin K; Kohler BA
    Cancer; 2020 May; 126(10):2225-2249. PubMed ID: 32162336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
    Chen J; Chen H; Zhang T; Yin X; Man J; Yang X; Lu M
    Pancreatology; 2022 Jun; 22(5):608-618. PubMed ID: 35513974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates?
    Luo Q; Steinberg J; Yu XQ; Caruana M; Canfell K; O’Connell DL
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):437-445. PubMed ID: 33639658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050.
    Li C; Ekwueme DU
    Cancer Epidemiol; 2010 Aug; 34(4):368-72. PubMed ID: 20510666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050.
    Sharma R
    Int J Clin Oncol; 2022 Apr; 27(4):665-675. PubMed ID: 35020103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.
    Edwards BK; Howe HL; Ries LA; Thun MJ; Rosenberg HM; Yancik R; Wingo PA; Jemal A; Feigal EG
    Cancer; 2002 May; 94(10):2766-92. PubMed ID: 12173348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.
    Wang L; Lu B; He M; Wang Y; Wang Z; Du L
    Front Public Health; 2022; 10():811044. PubMed ID: 35252092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated Projection of US Cancer Incidence and Death to 2040.
    Rahib L; Wehner MR; Matrisian LM; Nead KT
    JAMA Netw Open; 2021 Apr; 4(4):e214708. PubMed ID: 33825840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current estimates of and future projections for adult deaths attributed to HIV infection in Zimbabwe.
    Robinson NJ; Marindo R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):187-94. PubMed ID: 10048907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer trends in Sweden until 2010.
    Acta Oncol; 1996; 35 Suppl 6():37-45. PubMed ID: 9154084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of cancer incidence and mortality in elderly population in China, 2013].
    Chen WQ; Zheng RS; Zhang SW; Zeng HM; Zou XN; He J
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):60-66. PubMed ID: 28104036
    [No Abstract]   [Full Text] [Related]  

  • 38. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030.
    Quante AS; Ming C; Rottmann M; Engel J; Boeck S; Heinemann V; Westphalen CB; Strauch K
    Cancer Med; 2016 Sep; 5(9):2649-56. PubMed ID: 27356493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
    Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
    Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.
    Fidler MM; Gupta S; Soerjomataram I; Ferlay J; Steliarova-Foucher E; Bray F
    Lancet Oncol; 2017 Dec; 18(12):1579-1589. PubMed ID: 29111259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.